Login / Signup

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.

Elisa GelliDebora SonciniPamela BecheriniClaudia MartinuzziKatia TodoertiAntonia CagnettaSara AquinoFabio GuoloMaurizio MiglinoSantina BruzzoneAlessio NencioniAntonino NeriRoberto Massimo LemoliMichele Cea
Published in: Blood advances (2023)
Keyphrases
  • climate change
  • multiple myeloma
  • cancer therapy
  • oxidative stress
  • newly diagnosed
  • ischemia reperfusion injury
  • drug delivery